SCHEMBL3828923

SCHEMBL3828923

COCCNc1ccc(-c2[nH]c(-c3ccccc3/C=C/c3nc4ccccc4o3)nc2-c2ccc(N(C)C)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NOX1 Q9Y5S8 1/20 0.40
▸ ALDH1A1 P00352 4/20 0.39
▸ MAPT P10636 3/20 0.39
▸ CYP2D6 P10635 3/20 0.39
▸ KDM4E B2RXH2 3/20 0.39
▸ HPGD P15428 3/20 0.39
▸ CYP1A2 P05177 2/20 0.39
▸ CYP3A4 P08684 2/20 0.39
▸ CYP2C19 P33261 2/20 0.39
▸ LMNA P02545 1/20 0.39
▸ TP53 P04637 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ HBB P68871 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ CETP P11597 1/20 0.38
▸ RXFP1 Q9HBX9 1/20 0.38
▸ ALOX5 P09917 1/20 0.35
▸ USP2 O75604 1/20 0.33
▸ MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6609826 0.88 NOX1 (0.51) NOX1ALDH1A1MAPTKDM4EHPGD
SCHEMBL3824183 0.87 NOX1 (0.45) NOX1ALDH1A1MAPTCYP2D6KDM4E
SCHEMBL3830694 0.80 MEN1 (0.37) NOX1MAPTLMNATP53HBB
SCHEMBL3825381 0.73 KDM4E (0.36) ALDH1A1MAPTKDM4EHPGDHSD17B10
SCHEMBL8720952 0.70 MAPT (0.43) NOX1ALDH1A1MAPTKDM4EHPGD
SCHEMBL3826536 0.69 MEN1 (0.48) NOX1ALDH1A1MAPTCYP2D6CYP1A2
SCHEMBL6607624 0.69 MEN1 (0.55) NOX1ALDH1A1MAPTCYP2D6KDM4E
SCHEMBL8723120 0.64 MAPT (0.36) ALDH1A1MAPTKDM4EHPGDLMNA
SCHEMBL29397958 0.63 MEN1 (0.59) MAPTKDM4ERXFP1MAPK1MEN1
SCHEMBL476616 0.63 MEN1 (0.59) MAPTKDM4ERXFP1MAPK1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0999835-B1 IMIDAZOLE DERIVATIVES AS MDR MODULATORS TAIJI BIOMEDICAL INC (US) 2009-09-09 — — EP disclosed
EP-2082740-A2 Use of imidazole derivatives as MDR modulators Taiji Biomedical, Inc. (US) 2009-07-29 — — EP disclosed
EP-0999835-A4 IMIDAZOLE DERIVATIVES AS MDR MODULATORS ONTOGEN CORP (US) 2004-08-25 — — EP disclosed
EP-0999835-A1 IMIDAZOLE DERIVATIVES AS MDR MODULATORS Ontogen Corporation (US) 2000-05-17 — — EP disclosed
WO-1999002155-A1 IMIDAZOLE DERIVATIVES AS MDR MODULATORS ONTOGEN CORPORATION (US) 1999-01-21 — — WO disclosed
US-5840721-A INCREASE SENSITIVITY OF MULTIDRUG RESISTANT TUMOR CELLS TO ANTICANCER AGENTS ONTOGEN CORPORATION (US) 1998-11-24 — — US disclosed
Send feedback